Overview
Mark Seraly is a Dermatologist in Canonsburg, Pennsylvania. Dr. Seraly is highly rated in 6 conditions, according to our data. His top areas of expertise are Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, Neurocutaneous Melanosis, and Vitrectomy.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- OTHER COMMERCIAL
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
222 E McMurray Rd, Canonsburg, PA 15317
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UPMC North Hills Dermatology
Anuradha Bishnoi, MD, specializes in dermatology. She practices at UPMC North Hills Dermatology and UPMC Shadyside Dermatology. Dr. Bishnoi received her medical degree from Maharshi Dayanand University and completed her residency at the Postgraduate Institute of Medical Education and Research. Dr. Bishnoi is highly rated in 22 conditions, according to our data. Her top areas of expertise are Hypomelanotic Disorder, Vitiligo, Lichen Planus, and Melasma.
Office
Oleg Akilov is a Dermatologist in Pittsburgh, Pennsylvania. Dr. Akilov is highly rated in 7 conditions, according to our data. His top areas of expertise are Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.
Office
Laura Ferris is a Dermatologist in Pittsburgh, Pennsylvania. Dr. Ferris is highly rated in 7 conditions, according to our data. Her top areas of expertise are Psoriasis, Plaque Psoriasis, Melanoma, and Familial Atypical Multiple Mole Melanoma Syndrome.
Frequently Asked Questions about Dr. Mark Seraly
How do I make an appointment with Dr. Mark Seraly?
You can book an appointment with Dr. Mark Seraly by calling their office at 724-969-2500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark Seraly a top-rated expert for Giant Congenital Melanocytic Nevus?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Seraly is classified as an Advanced expert for Giant Congenital Melanocytic Nevus, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark Seraly specialize in?
While Dr. Mark Seraly is a Dermatology, they have specific expertise in Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.
Does Dr. Mark Seraly participate in research or clinical trials?
Yes. Dr. Mark Seraly has published 6 articles and abstracts on conditions like Giant Congenital Melanocytic Nevus. You can view a list of Dr. Mark Seraly's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark Seraly accept my insurance?
Dr. Mark Seraly accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 724-969-2500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Actinic KeratosisDr. Seraly isAdvanced. Learn about Actinic Keratosis.
- Familial Atypical Multiple Mole Melanoma Syndrome
- Giant Congenital Melanocytic Nevus
- Giant Congenital NevusDr. Seraly isAdvanced. Learn about Giant Congenital Nevus.
- MelanomaDr. Seraly isAdvanced. Learn about Melanoma.
- Neurocutaneous MelanosisDr. Seraly isAdvanced. Learn about Neurocutaneous Melanosis.
- Experienced
- Autoerythrocyte SensitivityDr. Seraly isExperienced. Learn about Autoerythrocyte Sensitivity.
- Basal Cell Skin CancerDr. Seraly isExperienced. Learn about Basal Cell Skin Cancer.
- Bowen's DiseaseDr. Seraly isExperienced. Learn about Bowen's Disease.
- Cafe-Au-Lait SpotsDr. Seraly isExperienced. Learn about Cafe-Au-Lait Spots.
- Cheilitis GlandularisDr. Seraly isExperienced. Learn about Cheilitis Glandularis.
- Contact DermatitisDr. Seraly isExperienced. Learn about Contact Dermatitis.